Drna stock after hours
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. DRNA Stock Quote - Dicerna Pharmaceuticals, Inc. Stock ... Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery and development of treatments for rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. Dicerna Pharmaceuticals, Inc. (DRNA) - NASDAQ.com Stock Details Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain CHARTS Basic Chart Interactive Chart COMPANY NEWS Company Headlines Press Releases Market Stream STOCK ANALYSIS Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison FUNDAMENTALS Moderna, Inc. - MRNA - Stock Price Today - Zacks
Open. 18.13. Previous Close. 18.30. Volume (Avg). 328.19k (866.54k). Day's Range. 17.62-19.03. 52Wk Range. 10.70-27.68. Market Cap. 1.32B. Dividend Rate
OTC Markets | DRNA Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. Stocks making the biggest moves after hours: Urban ... Nov 19, 2019 · Stocks making the biggest moves after hours: Urban Outfitters, Amarin, Endo International and more. Published Tue, Nov 19 2019 6:00 PM EST. Stock Quotes, and Market Data and Analysis.
DRNA Stocks -8.84% Far from 50 Day Moving Average. After a stumble in the market that brought DRNA to its low price for the period of the last 52 weeks, Dicerna Pharmaceuticals, Inc. was unable to take a rebound, for now settling with -26.48% of loss for the given period.
DRNA - Dicerna Pharmaceuticals Summary, Stock ... - Benzinga Jan 01, 2010 · Dicerna Pharmaceuticals (NASDAQ: DRNA) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers Dicerna Pharmaceuticals, Inc. (DRNA) SEC Filings - NASDAQ.com
Dicerna Pharmaceuticals, Inc. Common Stock (DRNA) After ...
Dicerna Pharmaceuticals, Inc. (DRNA) SEC Filings - NASDAQ.com Mar 13, 2020 · Dicerna Pharmaceuticals, Inc. (DRNA) SEC Filings - Get realtime SEC filings forDicerna Pharmaceuticals, Inc. and all the companies you research at NASDAQ.com
After hours winners and losers, along with futures charts of S&P 500, Nasdaq and Dow Jones.
Here's a roundup of top developments in the biotech space over the last 24 hours .Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18) * View today's stock price, news and analysis for Dicerna Pharmaceuticals Inc. ( DRNA). Barron's also provides $17.90. 0.00 (0%). After Hours Vol 8.9K. 18 Mar 2020 Dicerna Pharmaceuticals (NASDAQ: DRNA) shares are trading higher after the company received orphan drug designation from the FDA for Dicerna Pharmaceuticals (NASDAQ: DRNA) stock research, profile, news, analyst 7 Stocks Moving In Wednesday's After-Hours Session Tyree Gorges Wed, DRNA, Dicerna Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Investor's Business Daily 03/31/2020 03:00 AM ET View live DICERNA PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, DRNA financials and market news. DRNA Dicerna Pharmaceuticals, Inc. daily Stock Chart Market Cap, 1.49B, Forward P/E, -, EPS next Y, -0.37, Insider Trans, -98.78%, Shs Float, 68.18 Mar -26-20 04:05PM, Dicerna Addresses Business Continuity in Response to COVID- 19
View today's stock price, news and analysis for Dicerna Pharmaceuticals Inc. (DRNA). Barron's also provides information on historical stock ratings, target prices, company earnings, market DRNA | Stock Snapshot - Fidelity Apr 03, 2020 · Dicerna Pharmaceuticals, Inc. (DRNA), a leading developer of investigational ribonucleic acid interference therapeutics, today announced that the Compensation Committee of the Company's Board of Directors approved inducement grants of stock options to purchase a total of 136,300 shares of common stock and 38,600 restricted stock units to be On The Fly - On The Fly: After Hours Movers SCS;DRNA;NBRV ... On The Fly: After Hours Movers. UP AFTER EARNINGS: Steelcase (SCS), up 3.5% after reporting Q2 earnings and giving Q3 guidance. ALSO HIGHER: Dicerna (DRNA), higher by 5.26% after Bain Capital Life Sciences Partners discloses a position in the company Nabriva Therapeutics (NBRV). up 6% after filing to sell $80M in common stock. DRNA - Dicerna Pharmaceuticals Inc Stock quote - CNNMoney.com Find real-time DRNA - Dicerna Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. DRNA - Dicerna Pharmaceuticals Inc Stock quote - CNNMoney.com Markets